Download
indications for liver transplantation n.
Skip this Video
Loading SlideShow in 5 Seconds..
Indications for Liver Transplantation PowerPoint Presentation
Download Presentation
Indications for Liver Transplantation

Indications for Liver Transplantation

33 Vues Download Presentation
Télécharger la présentation

Indications for Liver Transplantation

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Indications for Liver Transplantation Dr.K.PANDURANGA RAO

  2. The largest single organ in the human body. In an adult, it weighs about 1.5 Kg and is roughly the size of a football. Located in the upper right-hand part of the abdomen, behind the lower ribs. The Liver

  3. The liver is divided) into four lobes: the right (the largest lobe), left, quadrate and caudate lobes. Supplied with blood via the protal vein and hepatic artery. Blood carried away by the hepatic vein. It is connected to the diaphragm and abdomainal walls by five ligaments. Gall Bladder Muscular bag for the storage, concentration, acidification and delivery of bile to small intestine The liver is the only human organ that has the remarkable property of self-regeneration. If a part of the liver is removed, the remaining parts can grow back to its original size and shape. Gross Anatomy

  4. Microscopic Anatomy

  5. What does the liver do? Multi-function, blood-processing “factory” • Temporary nutrient storage (glucose-glycogen) • Remove toxins from blood • Remove old/damaged RBC’s • Regulate nutrient or metabolite levels in blood—keep constant supply of sugars, fats, amino acids, nucleotides (including cholesterol) • Secrete bile via bile ducts and gall bladder into small intestines.

  6. LIVER FUNCTION TESTS • ALT • AST (SGOT) • ALKALINE PHOSPHATASE • BILIRUBIN • PROTHROMBIN TIME/INR • ALBUMIN

  7. Acute and Chronic Liver Disease

  8. Acute Liver Disease • Infections • Viral Hepatitis A, B, C, D, E, EBV, CMV, HSV, • Others – Leptospirosis, Toxoplasma, • Drugs – MANY – HERBALS/OTC • Alcohol • Toxins • Vascular obstruction (eg. Budd-Chiari)

  9. Acute Liver failure(ALF) • ALF is defined as hepatic encephalopathy occurring within 24 weeks of the onset of symptoms in patients with out preexisting liver disease.

  10. Categorization of FHF Based on the time interval between onset of jaundice and encephalopathy • HyperacuteLiver Failure 7 days or less • Acute Liver Failure 8 to 28 days • Subacute Liver Failure 5-24 weeks O’Grady et al.

  11. Aetiology of FHF in india • Aetiology of FHF in india • Acharaya et al Jaiswal et al (1999) (1996) No of Pt458 95 • HAV 4% 4.2% • HBV 10.5% 27.3% • HCV 4.4% 2.1% • HDV 0% 5.2% • HEV 23% 41% • Mixed 6.3% 4.1% • Non A, Non B 47% 15% • Drugs 5% 0%

  12. Chronic Liver Disease • Alcohol • Viral hepatitis: B & C • Autoimmune – autoimmmune hepatitis, PBC (Primary Biliary cirrhosis), PSC (Primary Sclerosing Cholangitis) • Non-alcoholic fatty liver disease (NAFLD) • Drugs (MTX, amiodarone) • Haemochromatosis • Cystic fibrosis, a1antitryptin deficiency, Wilsons disease, • Vascular problems (Portal hypertension + liver disease) • Cryptogenic • Others: sarcoidosis, amyloid, schistosomiasis

  13. What is Cirrhosis?

  14. Cirrhosis Definition: Hepatic necrosis and degeneration combined with hepatic regeneration and fibrosis leading to Nodular formation

  15. Cirrhosis Of Liver

  16. Complications of cirrhosisVaricealhaemorrhage

  17. Complications of cirrhosisAscites

  18. Hepato Renal Syndrome

  19. Complications of cirrhosisHepatic Encephalopathy

  20. Liver Transplantation • Liver transplantation (LT) is now established as the only definitive treatment for end stage liver disease (ESLD) • Starzl et al carried out 1st human liver transplant in 1963 • Survival following liver transplant • 1 year survival: 87 – 93% • 3 year survival: > 75% .....(http://www.ustransplant.org The 2009 Annual Report of the OPTN and SRTR: Transplant Data 1999-2008).

  21. Liver Transplantation Issues • Whether patient needs LT? • When to refer or consider for LT? • Is patient suitable for LT?

  22. Scoring systems CHILD-TURCOTTE - PUGH SCORE CTP score: - Disease severity for pts with ESLD - Used to predict peri-operative mortality in patients with liver disease.

  23. Shortcomings of CTP scores • Subjective nature of the assessment of ascites & encephalopathy • Limited discrimination into only three disease severity categories

  24. Model for End-Stage Liver Disease (MELD) • MELD score = 0.957 x Loge (creatinine mg/dl) + 0.378 x Loge (bilirubin mg/dl) + 1.12 x Loge (INR) + 0.643 Multiply the score by 10 and round to the nearest whole number • Established in Feb 2002 • Numerical scale, from 6 (less ill) to 40 (gravely ill) • This ‘score’ tells us how urgently LT is required within next 3 months • Most patients on LT waiting list have MELD score between 11 and 20

  25. Upper limit of MELD.Estimated Survival • A retrospective longitudinal cohort study in 232 patients • The estimated survival for patients with MELD score > 25 was lower at 12 months (68.86% vs 39.13%). • Ilka Fatima Ferreira Santana Boin et al, ArqGastroenterol. 2008 Oct- ec;45(4):275-83

  26. Indications for Liver Transplantation Proportion of liver transplants for specific etiologies, 1992–2007 O’Leary et al Gastroenterology 2008

  27. Indications for Liver Transplantation

  28. Main indications for LTx: complications of ESLD • GE variceal bleed- each episode of bleeding carries a 20% mortaliity rate. LT is the best way to decompress the portal system if other therapies have failed. – De Francis et al, Baveno V, J Hepatology, 2010] • HE- LT remains the only permanent Rx

  29. Main indications for LTx: complications of ESLD 3. Refractory ascites- • carries a mortality of >50% at 2 yrs. • More prone for variceal bleed, HRS, SBP. • Annual incidence of HRS in cirrhotics with ascites is 8% with median survival of 2 wks in Type I and 6 months in Type II. • LT should be considered as soon as HRS is diagnosed. Planas et al, Clini gastro hepatology 2006;4:1385-94 Gines A et al, Gastroenterology 1993;105:229-36

  30. Main indications for LTx: complications of ESLD 4. HPS- [4-47% prevalence] LT is the only curative Rx for HPS 5. PPHTN- 2-8%, associated with higher post transplantation mortality Individual etiologies – viral hepatitis, ALD, NAFLD, HPB malignancy, AIH, Cholestatic disorders, ALF, HCC.

  31. Need for LT • CTP and MELD most commonly used • PBC/PSC have their own prognostic scores • 5-year survival (CTP 7-15) with (ascites, bleeding, HE, SBP, HRS) : 20% to 50% • Survival rates 1, 3, and 5 years after LT 88%, 80%, and 75% -Shetty K et al Hepatology 1997 -Kamath PS et al Hepatology 2001 -Freeman RB et al Liver Transpl 2004 -H-C Huang et al. Journal of Gastroenterology and Hepatology 24 (2009) 1716–1724 Predictive accuracy for short-term mortality

  32. In pts with MELD<14, the mortality with LTx > not undergoing LTx • Comparison of mortality risk expressed as hazard ratio by MELD score for recipients of liver transplants compared to candidates on the liver transplant waiting list – Merion et al, Am J transplantation 2005;5:307-13

  33. Referred for LT when (CTP > 7 and MELD > 10) or they experience their first major complication (ascites, bleeding, or HE) - AASLD:Karen F et al Hepatology 2005 • Berg CL et al Gastroenterology 2007 • MELD under estimates – HCC, CholangioCa, HE, ascites, HPS, PPHTN, GI bleed etc

  34. Contraindication for LT x x x

  35. Donor Liver Allocation …… Liver Donor • In US, patients name and condition is entered in National Registry • CTP (CHILD-TURCOTTE - PUGH SCORE) scores in conjunction with United Network for Organ Sharing (UNOS) status determining factor was used for organ allocation in the USA until early 2002. but it did not always ensure that organs were allocated to the sickiest patients with the greatest risk of mortality. • Now, Model for End-Stage Liver Disease (MELD) is used • for allocating liver to recepients. • In India, there is no such national registry or liver transplant • centre registry.

  36. Thank you